ArticleCancers2026

Long-Term Risk of Residual or Recurrent CIN 2-3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study.

Christian Leonardo Molina-Hinojosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.